Cargando…
Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer
Endometrial cancer is the fourth most commonly diagnosed cancer in women. Family history is a known risk factor for endometrial cancer. The incidence of endometrial cancer in a first-degree relative elevates the relative risk to range between 1.3 and 2.8. It is unclear to what extent or what other n...
Autores principales: | Shivakumar, Manu, Miller, Jason E., Dasari, Venkata Ramesh, Gogoi, Radhika, Kim, Dokyoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626914/ https://www.ncbi.nlm.nih.gov/pubmed/31338326 http://dx.doi.org/10.3389/fonc.2019.00574 |
Ejemplares similares
-
Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019) -
Correction to: Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019) -
Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
por: Pandi, Maria-Theodora, et al.
Publicado: (2020) -
Differential gene expression induced by Verteporfin in endometrial cancer cells
por: Bang, Lisa Gahyun, et al.
Publicado: (2019) -
Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2017)